Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity

NCT05017571 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

NIH

Sponsor class

Conditions

Obesity
Insulin Resistance
Inflammation

Interventions

DRUG: Colchicine
DRUG: Placebo

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)